collection date unit number expires anticoagulant citrate ...€¦ · cp2d whole blood...

2
CP2D WHOLE BLOOD ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION Collection Date Unit Number EXPIRES VOLUNTEER DONOR 70 ml Anticoagulant Citrate Phosphate Double Dextrose Solution for collection of 500 ml of blood. Each 70 ml of CP2D solution contains 3.57 g dextrose (monohydrate), USP; 1.84 g sodium citrate (dihydrate), USP; 0.229 g citric acid (monohydrate), USP; and 0.155 g monobasic sodium phosphate (monohydrate), USP. Use only if solution is clear. 670126930 CP2D 500 Affix Collection/Processing I.D. Label Here See circular of information for indications, contraindications, cautions and methods of infusion. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT. 126 - 93 0800643 Approx. 500 ml plus 70 ml CP2D. Store at 1 – 6 C. o 00180 84 LOT Pall Corporation East Hills, NY 11548, USA 0000800643 1PA0012693 AS-3 RED BLOOD CELLS ADENINE - SALINE ADDED LEUKOCYTES REDUCED Collection Date Unit Number EXPIRES VOLUNTEER DONOR 670126930 CP2D 500 Affix Collection/Processing I.D. Label Here See circular of information for indications, contraindications, cautions and methods of infusion. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT. 126 - 93 0800643 From 500 ml CP2D Whole Blood Store at 1 – 6 C. o 04730 84 LOT Pall Corporation East Hills, NY 11548, USA 0000800643 1PA0012693 Place Product Label here after bag is filled. PLASMA BAG LEUKOCYTES REDUCED Collection Date Unit Number EXPIRES VOLUNTEER DONOR 670126930 CP2D 500 Affix Collection/Processing I.D. Label Here See circular of information for indications, contraindications, cautions and methods of infusion. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT. 126 - 93 0800643 02 LOT Pall Corporation East Hills, NY 11548, USA 0000800643 1PA0012693 Affix grouping label here after all required testing has been completed. Place Product Label here after bag is filled. LEUKOCYTES REDUCED Collection Date Unit Number EXPIRES VOLUNTEER DONOR 670126930 CP2D 500 Affix Collection/Processing I.D. Label Here See circular of information for indications, contraindications, cautions and methods of infusion. This product may transmit infectious agents. Rx only. PROPERLY IDENTIFY INTENDED RECIPIENT. 126 - 93 0800643 02 LOT Pall Corporation East Hills, NY 11548, USA 0000800643 1PA0012693 110 ml of preservative AS-3 solution contains 1.21 g dextrose (monohydrate), USP; 0.647 g sodium citrate (dihydrate), USP; 0.451 g sodium chloride, USP; 0.304 g monobasic sodium phosphate (monohydrate), USP; 0.046 g citric acid (monohydrate), USP; and 0.333 g adenine, USP. Contain 16.5 mEq of sodium. Use only if solution is clear. WHERE DOES MY BLOOD GO? The Life Saving Journey Explained Blood flows into the diversion pouch • Before blood flows into the whole blood collection bag, a small portion is diverted into the diversion pouch. • The diversion pouch captures the small amount of skin that is picked up when the needle is inserted. • This blood is transferred into pilot tubes that are used for testing. Blood is diverted to the collection bag Once the diversion pouch is full, blood flows into the whole blood collection bag (see above). Leukocytes are reduced Once the whole blood is separated into individual components, a filter (see left) removes most of the white blood cells (leukocytes) from red blood cells and platelets. Platelets Platelets are a cellular element needed for blood to clot properly. Platelets can be processed from whole blood (see left), or they can be collected individually by an automated process known as apheresis. Platelets are used to correct low platelet counts (thrombocytopenia) in patients undergoing chemotherapy, or other conditions in which the patient loses platelets, such as massive trauma. Blood Component Therapy Blood component therapy is made possible because single whole blood donations are manufactured into the individual components of red blood cells, platelets, plasma, and cryoprecipitate. As a result, one donation can benefit multiple patients. Red Blood Cells Red blood cells transport oxygen to the body’s tissues. Red blood cells are transfused to treat anemia resulting from, for example, kidney failure, chemotherapy regimens, gastrointestinal bleeding or blood loss due to trauma or surgery. Plasma Plasma is the liquid portion of the blood, in which the red cells, white cells and platelets are suspended. • It carries clotting factors, electrolytes, nutrients, hormones and antibodies as it circulates throughout the body. Plasma is transfused to burn patients and patients suffering massive hemorrhage due to trauma or disease. Cryoprecipitate Cryoprecipitate is a specialty product that is made and used in the treatment of von-Willebrand disease and to replace fibrinogen. It is made from frozen plasma thru a process that leaves only Factor VIII, fibrinogen and von Willebrand factor. 1 2 3 WhereDoesMyBloodGo_brochure_2017_Revision.indd 1 2/1/17 2:38 PM

Upload: others

Post on 31-Oct-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Collection Date Unit Number EXPIRES ANTICOAGULANT CITRATE ...€¦ · CP2D WHOLE BLOOD ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION Collection Date Unit Number EXPIRES

CP2D WHOLE BLOOD

ANTICOAGULANTCITRATEPHOSPHATEDOUBLE DEXTROSESOLUTION

Collection Date Unit Number EXPIRES

VOLUNTEER DONOR

70 ml Anticoagulant Citrate Phosphate DoubleDextrose Solution for collection of 500 ml ofblood. Each 70 ml of CP2D solution contains 3.57 g dextrose (monohydrate), USP; 1.84 gsodium citrate (dihydrate), USP; 0.229 g citricacid (monohydrate), USP; and 0.155 g monobasic sodium phosphate (monohydrate),USP. Use only if solution is clear.

670126930

CP2D500

A�xCollection/Processing

I.D. Label Here

See circular of information for indications,contraindications, cautions and methods of infusion.

This product may transmit infectious agents. Rx only.

PROPERLY IDENTIFY INTENDED RECIPIENT.

126 - 93 0 8 0 0 6 4 3

Approx. 500 mlplus 70 ml CP2D.Store at 1 – 6 C.o

00180

84

LOTPall CorporationEast Hills, NY 11548, USA

00008006431PA0012693

AS-3 RED BLOOD CELLSADENINE - SALINE ADDED

LEUKOCYTES REDUCED

Collection Date Unit Number EXPIRES

VOLUNTEER DONOR

670126930

CP2D500

A�xCollection/Processing

I.D. Label Here

See circular of information for indications,contraindications, cautions and methods of infusion.

This product may transmit infectious agents. Rx only.

PROPERLY IDENTIFY INTENDED RECIPIENT.

126 - 93 0 8 0 0 6 4 3

From 500 mlCP2D Whole BloodStore at 1 – 6 C.o

04730

84

LOTPall CorporationEast Hills, NY 11548, USA

00008006431PA0012693

Place Product Labelhere after bag is �lled.

PLASMA BAG

LEUKOCYTES REDUCED

Collection Date Unit Number EXPIRES

VOLUNTEER DONOR

670126930

CP2D500

A�xCollection/Processing

I.D. Label Here

See circular of information for indications,contraindications, cautions and methods of infusion.

This product may transmit infectious agents. Rx only.

PROPERLY IDENTIFY INTENDED RECIPIENT.

126 - 93 0 8 0 0 6 4 3

02

LOTPall CorporationEast Hills, NY 11548, USA

00008006431PA0012693

A�x grouping label here after allrequired testing has been completed.

Place Product Labelhere after bag is �lled.

LEUKOCYTES REDUCED

Collection Date Unit Number EXPIRES

VOLUNTEER DONOR

670126930

CP2D500

A�xCollection/Processing

I.D. Label Here

See circular of information for indications,contraindications, cautions and methods of infusion.

This product may transmit infectious agents. Rx only.

PROPERLY IDENTIFY INTENDED RECIPIENT.

126 - 93 0 8 0 0 6 4 3

02

LOTPall CorporationEast Hills, NY 11548, USA

00008006431PA0012693

110 ml of preservative AS-3 solution contains1.21 g dextrose (monohydrate), USP; 0.647 g sodium citrate (dihydrate), USP; 0.451 g sodiumchloride, USP; 0.304 g monobasic sodiumphosphate (monohydrate), USP; 0.046 g citricacid (monohydrate), USP; and 0.333 g adenine,USP. Contain 16.5 mEq of sodium. Use only ifsolution is clear.

WHEREDOES

MYBLOOD

GO?The Life Saving Journey Explained

Blood flows into the diversion pouch

• Before blood flows into the whole blood collection bag, a small portion is diverted into the diversion pouch.

• The diversion pouch captures the small amount of skin that is picked up when the needle is inserted.

• This blood is transferred into pilot tubes that are used for testing.

Blood is diverted to the collection bag

• Once the diversion pouch is full, blood flows into the whole blood collection bag (see above).

Leukocytes are reduced

• Once the whole blood is separated into individual components, a filter (see left) removes most of the white blood cells (leukocytes) from red blood cells and platelets.

Platelets

• Platelets are a cellular element needed for blood to clot properly.

• Platelets can be processed from whole blood (see left), or they can be collected individually by an automated process known as apheresis.

• Platelets are used to correct low platelet counts (thrombocytopenia) in patients undergoing chemotherapy, or other conditions in which the patient loses platelets, such as massive trauma.

Blood Component Therapy

• Blood component therapy is made possible because single whole blood donations are manufactured into the individual components of red blood cells, platelets, plasma, and cryoprecipitate.

• As a result, one donation can benefit multiple patients.

Red Blood Cells

• Red blood cells transport oxygen to the body’s tissues.

• Red blood cells are transfused to treat anemia resulting from, for example, kidney failure, chemotherapy regimens, gastrointestinal bleeding or blood loss due to trauma or surgery.

Plasma

• Plasma is the liquid portion of the blood, in which the red cells, white cells and platelets are suspended.

• It carries clotting factors, electrolytes, nutrients, hormones and antibodies as it circulates throughout the body.

• Plasma is transfused to burn patients and patients suffering massive hemorrhage due to trauma or disease.

Cryoprecipitate

• Cryoprecipitate is a specialty product that is made and used in the treatment of von-Willebrand disease and to replace fibrinogen.

• It is made from frozen plasma thru a process that leaves only Factor VIII, fibrinogen and von Willebrand factor.

1 2

3

WhereDoesMyBloodGo_brochure_2017_Revision.indd 1 2/1/17 2:38 PM

Page 2: Collection Date Unit Number EXPIRES ANTICOAGULANT CITRATE ...€¦ · CP2D WHOLE BLOOD ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION Collection Date Unit Number EXPIRES

OHIOAdams County Regional Medical Center

Bethesda Butler HospitalBethesda North Hospital

Bethesda Medical Center at Arrow SpringsCincinnati Children’s Hospital Medical Center

CCHMC - Liberty CampusDaniel Drake Center for Post Acute Care

Good Samaritan HospitalHighland District Hospital

Mercy Health Anderson HospitalMercy Health Clermont HospitalMercy Health Fairfield Hospital

Mercy Health Rookwood Medical CenterMercy Health West Hospital

Shriners Hospitals for ChildrenSouthern Ohio Medical Center

The Christ Hospital

The Jewish HospitalTriHealth Evendale Hospital

University of Cincinnati Medical CenterVeterans Affairs Medical Center

West Chester Hospital West Chester Hospital Surgical Center

KENTUCKYSt. Elizabeth CovingtonSt. Elizabeth Edgewood

St. Elizabeth FlorenceSt. Elizabeth Ft. Thomas

St. Elizabeth Grant CountySt. Elizabeth Owen County

INDIANADearborn County Hospital

Margaret Mary Health

Who does Hoxworth serve?When you donate with Hoxworth Blood Center, you are helping patients in need of blood and blood components at 31 hospitals and medical centers in the Tri-State.

What is the rarest blood type?The rarest blood type is the one NOT on the shelf when it is needed.

Therefore, we need blood donors of ALL blood types to make regular donations so that we can ensure a safe and adequate blood supply for the communities we serve.

O negative is known as the Universal Donor, making up 7% of all individuals. In emergency situations, O negative red cells can be given to people with any blood type. Individuals who are AB positive can receive any type of red cells.

The chart below identifies percentages of the four main types of blood within the general population.

Blood Group Population Percentage Rh Positive Percentage Rh Negative Percentage

O 45% 38% 7%

A 40% 34% 6%

B 11% 9% 2%

AB 4% 3% 1%

What is in my blood?Blood is composed of plasma and cellular components

(red blood cells, white blood cells and platelets). The percentage of red blood cells in your blood is measured by the hematocrit test that is done prior to donation. In order to donate whole

blood, your hematocrit level must be at least 38% and to donate red cells your hematocrit must be at least 40%

Plasma substances and water(about 55 percent)

White blood cells and platelets(less than one percent)

Red blood cells(almost 45 percent)

How will my blood be used?Each day, Hoxworth Blood Center needs to collect at least 300 units of blood and 40 units of apheresis platelets to meet the needs of patients in the Tri-State area. Once testing and processing is complete, the units are dispersed

to the 31 hospitals served by Hoxworth where they are transfused to patients with a variety of medical needs.

These needs range from treatment of traumatic injuries to elective surgeries. The chart below indicates the average number of units that are needed for some of the many potential uses.

Examples of Blood Use

Auto Accident/Trauma

Heart Surgery

Cancer Patients

Organ or Bone Marrow Transplant

Burn Patients

Needed Donations

5 - 100 red cell donations

3 - 8 red cell donations,1 - 10 platelet donations

Rev. 2/17 Hox7-5221

Where can I donate?Hoxworth Blood Center has several, conveniently located, neighborhood donor centers and mobile blood drives. To schedule an appointment to

donate, call 513-451-0910 or 800-830-1091 or visit hoxworth.org.

You need to be 17-years-old (16 years with parental consent), weigh at least 110 pounds and generally feel healthy and well to donate.

3 - 10 red cell donations5 - 15 platelet donations

10 - 30 red cell donations,50 - 100 platelet donations

10 - 20 platelet donations

WhereDoesMyBloodGo_brochure_2017_Revision.indd 2 2/1/17 2:38 PM